PMS15 Costs of Tumor Necrosis Factor Blockers Per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population
Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.401
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV